Global survey of polymyxin use: A call for international guidelines

Journal of Global Antimicrobial Resistance

Volumn 1, Issue 3, 2013, Pages 131-134

  Wertheim, Heiman ^a,b   Van Nguyen, Kinh ^c   Hara, Gabriel Levy ^d   Gelband, Hellen ^e   Laxminarayan, Ramanan ^e,f   Mouton, Johan ^g   Cars, Otto ^h  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL HOSPITAL FOR TROPICAL DISEASES   (Viet Nam)

^d HOSPITAL DURAND   (Argentina)

^e Center for Disease Dynamics Economics and Policy   (United States)

^f PRINCETON UNIVERSITY   (United States)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UPPSALA UNIVERSITY   (Sweden)

Author keywords

Colistin; Global; Multidrug resistant; Polymyxin; Survey; Use

Indexed keywords

CARBAPENEM; COLISTIMETHATE; COLISTIN; FOSFOMYCIN; GENTAMICIN; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CATHETER INFECTION; EUROPE; GRAM NEGATIVE BACTERIUM; HUMAN; NORTH AMERICA; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPSIS; STRUCTURED QUESTIONNAIRE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84882434122     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2013.03.012     Document Type: Article

References (13)

1. T.R. Walsh, and M.A. Toleman The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response Journal of Antimicrobial Chemotherapy 67 2012 1 3
2. A.S. Michalopoulos, and D.C. Karatza Multidrug-resistant Gram-negative infections: the use of colistin Expert Review of Anti-infective Therapy 8 2010 1009 1017
3. L.M. Lim, N. Ly, D. Anderson, J.C. Yang, L. Macander, and A. Jarkowski 3rd Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing Pharmacotherapy 30 2010 1279 1291
4. A.S. Michalopoulos, D.C. Karatza, and L. Gregorakos Pharmacokinetic evaluation of colistin sodium Expert Opinion on Drug Metabolism & Toxicology 7 2011 245 255
5. S.M. Garonzik, J. Li, V. Thamlikitkul, D.L. Paterson, S. Shoham, and J. Jacob Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients Antimicrobial Agents and Chemotherapy 55 2011 3284 3294
6. P.J. Bergen, J. Li, and R.L. Nation Dosing of colistin - back to basic PK/PD Current Opinion in Pharmacology 11 2011 464 469
7. C. Pulcini, K. Bush, W.A. Craig, N. Frimodt-Moller, M.L. Grayson, and J.W. Mouton Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia Clinical Infectious Diseases 54 2012 268 274
8. D. Jabes The antibiotic R&D pipeline: an update Current Opinion in Microbiology 14 2011 564 569
9. S. Donadio, S. Maffioli, P. Monciardini, M. Sosio, and D. Jabes Antibiotic discovery in the twenty-first century: current trends and future perspectives Journal of Antibiotics 63 2010 423 430
10. D. Plachouras, M. Karvanen, L.E. Friberg, E. Papadomichelakis, A. Antoniadou, and I. Tsangaris Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria Antimicrobial Agents and Chemotherapy 53 2009 3430 3436
11. J. Garnacho-Montero, C. Ortiz-Leyba, F.J. Jiménez-Jiménez, A.E. Barrero-Almodóvar, J.L. García-Garmendia, and I.M. Bernabeu-Wittel Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP Clinical Infectious Diseases 36 2003 1111 1118
12. R.Y. Hachem, R.F. Chemaly, C.A. Ahmar, Y. Jiang, M.R. Boktour, and G.A. Rjaili Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients Antimicrobial Agents and Chemotherapy 51 2007 1905 1911
13. A. Antoniadou, F. Kontopidou, G. Poulakou, E. Koratzanis, I. Galani, and E. Papadomichelakis Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster Journal of Antimicrobial Chemotherapy 59 2007 786 790